NCT03492697 - A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

July 18, 2018

Study Completion Date

July 18, 2018

Conditions

Healthy Subjects

Interventions

DRUG

PF-06882961 Immediate Release Tablet

Immediate Release Tablet

DRUG

PF-06882961 Controlled Release Tablet (long)

Controlled Release tablet (long)

DRUG

PF-06882961 Controlled Release Tablet (short)

Controlled Release tablet (short)

DRUG

PF-06882961 Immediate Release Solution

PF-06882961 Immediate Release solution

Trial Locations (1)

Pfizer New Haven Clinical Research Unit, New Haven